153 related articles for article (PubMed ID: 37890354)
1. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract][Full Text] [Related]
2. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
[TBL] [Abstract][Full Text] [Related]
3. Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary.
Mazina V; Devins K; Philp L; Bercow AS; James K; Bregar A; Sisodia RC; Oliva E; Del Carmen M
Int J Gynecol Cancer; 2023 Sep; 33(9):1434-1439. PubMed ID: 37567599
[TBL] [Abstract][Full Text] [Related]
4. Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis.
Pecorino B; Laganà AS; Chiantera V; Ferrara M; Di Stefano AB; Di Donna MC; Sorrentino F; Nappi L; Mikuš M; Scollo P
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556908
[No Abstract] [Full Text] [Related]
5. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
[TBL] [Abstract][Full Text] [Related]
6. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
[TBL] [Abstract][Full Text] [Related]
7. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
9. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
[TBL] [Abstract][Full Text] [Related]
10. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
Farrell R; Dixon SC; Carter J; Webb PM
Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
[TBL] [Abstract][Full Text] [Related]
11. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
Bassarak N; Blankenstein T; Brüning A; Dian D; Bergauer F; Friese K; Mylonas I
BMC Cancer; 2010 May; 10():224. PubMed ID: 20492712
[TBL] [Abstract][Full Text] [Related]
12. Impact of lymph node staging in presumed early-stage ovarian carcinoma.
Rodrigues Teixeira F; Vertematti de Castro V; Chaves Faloppa C; Mantoan H; Yuri Kumagai L; Narcizo Oliveira Menezes A; Badiglian-Filho L; De Brot L; Tirapelli Goncalves B; Paiva Gadelha Guimaraes A; Baiocchi G
Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():6-10. PubMed ID: 36108452
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
14. Does para-aortic lymphadenectomy improve survival in pathologically diagnosed early-stage grade 3 endometrioid and non-endometrioid endometrial cancers? A retrospective cohort study in Korea and Taiwan.
Lai YL; Chang CS; Chang K; Kim HS; Chen J; Cheng WF; Chen YL; Lee YY
Gynecol Oncol; 2022 Oct; 167(1):65-72. PubMed ID: 35995599
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
16. Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy - A population-based cohort study.
Åkesson Å; Adok C; Dahm-Kähler P
Eur J Cancer; 2022 Jul; 169():54-63. PubMed ID: 35500461
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
18. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
19. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
20. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
Seagle BL; Kocherginsky M; Shahabi S
JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
